Identifying, developing and commercializing urgently needed ophthalmic medicines and devices, to enhance the diagnosis and treatment of diseases, and drive bio-technology breakthrough in the ophthalmology field

A large number of patients suffer from eye diseases in China. With population growth and aging, the burden of eye diseases is increasing significantly. Based on professional ophthalmic product portfolio, extensive expert and channel resources, CMS’ ophthalmology business (“CMS Vision”) focuses on identification, development and commercialization of urgent needed ophthalmic diagnosis and treatment, to accelerate development of innovative technologies in the ophthalmology field.

Ophthalmology Line

EyeOP1 Glaucoma Treatment Device

Glaucoma with intraocular pressure cannot be controlled by drugs and surgery


Augentropfen Stulln Mono (Esculin and Digitalisglycosides Eye Drops)

- Senile macula degeneration
- All forms of asthenopia i.e. symptoms of fatigue of muscular, nervous or accommodative origin

The information on this page is only for the introduction of the medicines and medical devices to partners or medical professionals, not for product advertising. The product information on this website shall not replace medical advice and medical consultation provided by doctors or other qualified medical professionals, and shall not be used for disease diagnosis. For detailed information about the medicines and medical devices, please refer to the latest product instructions. If you have understood and confirmed the above content, please click OK to enter.